2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schizophrenia Opportunity
https://ir.nrxpharma.com/2024-05-14-NRx-Pharm...ess-Update
#PharmaNews #mentalillness #mentalhealth #mentalhealthawareness #mentalhealthmatters #depression #ketamine #stress #PTSD #bipolar #NRX100 #NRX101